Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study - Yana, T; Negoro, S; Takada, M (Invest New Drugs, 2007)
, et al; West Japan Thoracic Oncology Group.